PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
7.60%
Revenue growth 1.25-1.5x AVGO's 5.51%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
7.95%
Gross profit growth above 1.5x AVGO's 4.31%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
11.19%
EBIT growth above 1.5x AVGO's 6.66%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
11.19%
Operating income growth above 1.5x AVGO's 6.66%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
21.88%
Net income growth above 1.5x AVGO's 9.27%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
21.21%
EPS growth above 1.5x AVGO's 10.96%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
23.71%
Diluted EPS growth above 1.5x AVGO's 8.45%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.20%
Slight or no buybacks while AVGO is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.28%
Slight or no buyback while AVGO is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
-0.20%
Dividend reduction while AVGO stands at 4.77%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
99.67%
OCF growth above 1.5x AVGO's 3.59%. David Dodd would confirm a clear edge in underlying cash generation.
112.63%
FCF growth above 1.5x AVGO's 3.55%. David Dodd would verify if the firm’s strategic investments yield superior returns.
683.17%
10Y revenue/share CAGR at 75-90% of AVGO's 764.88%. Bill Ackman would press for new markets or product lines to narrow the gap.
210.71%
5Y revenue/share CAGR above 1.5x AVGO's 83.01%. David Dodd would look for consistent product or market expansions fueling outperformance.
237.21%
3Y revenue/share CAGR above 1.5x AVGO's 49.34%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
621.63%
10Y OCF/share CAGR at 50-75% of AVGO's 1175.86%. Martin Whitman might fear a structural deficiency in operational efficiency.
271.61%
5Y OCF/share CAGR above 1.5x AVGO's 132.24%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
228.58%
3Y OCF/share CAGR above 1.5x AVGO's 78.58%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
2428.00%
Net income/share CAGR above 1.5x AVGO's 1164.46% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
305.01%
5Y net income/share CAGR at 50-75% of AVGO's 424.29%. Martin Whitman might see a shortfall in operational efficiency or brand power.
415.25%
3Y net income/share CAGR 1.25-1.5x AVGO's 283.07%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
526.98%
10Y equity/share CAGR 1.25-1.5x AVGO's 461.90%. Bruce Berkowitz would see if strong ROE or conservative payout policy fosters faster book value growth.
308.00%
5Y equity/share CAGR above 1.5x AVGO's 10.57%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
177.13%
Positive short-term equity growth while AVGO is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
16.24%
Below 50% of AVGO's 325.24%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
-0.73%
Negative near-term dividend growth while AVGO invests at 63.31%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
17.60%
AR growth well above AVGO's 9.23%. Michael Burry fears inflated revenue or higher default risk in the near future.
16.66%
Inventory growth well above AVGO's 4.73%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
8.75%
Asset growth above 1.5x AVGO's 2.70%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
11.60%
Similar to AVGO's 10.89%. Walter Schloss finds parallel capital usage or profit distribution strategies.
No Data
No Data available this quarter, please select a different quarter.
4.49%
We increase R&D while AVGO cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
1.08%
SG&A declining or stable vs. AVGO's 14.55%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.